COO The Cooper Companies, Inc. Projected Price to Earnings

Brandmark of CooperSurgical (COO)

Asset diversification between ophthalmology and women's health protects The Cooper Companies (COO) from market volatility. Effective management ensures double-digit revenue growth through the strategic integration of new divisions. The company's forward P/E NTM demonstrates market expectations, where the 13.30 mark reflects the latest data. Low geopolitical risks and the humanitarian status of its products make the business resilient to trade sanctions.

COO - coopercos.com Projected Price to Earnings Ratio over the range 07/04/2022 - 11/13/2026

Financial and market metric breakdowns for CooperSurgical (COO)

- stock quotes and analyst forecast:
Stock Price CooperCompanies|COO - Analyst Median Target
- market capitalization data:
Market Valuation The Cooper Companies, Inc.|COO - Full Business Value
- issuer book value statistics:
Book Value per Share CooperCompanies|COO - Total Stockholders' Equity|Market Capitalization to Book Value Ratio coopercos.com|COO - Total Business Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio The Cooper Companies|COO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity The Cooper Companies|COO - Company Total Debt|Debts to Book Capitalization The Cooper Companies, Inc.|COO - Long-Term Debt|Company Short-Term Debts CooperCompanies|Quick Ratio coopercos.com
- earnings and market ratios statistics:
COO - Net Financial Result|Projected Future Earnings The Cooper Companies|COO - Price to Earnings Ratio|Forward P/E Multiple CooperVision|COO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Cooper Companies, Inc.|COO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months CooperCompanies|COO - Earnings per share for the trailing year|Quarterly EPS earnings growth coopercos.com|COO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year The Cooper Companies
Fundamental company analysis:CooperCompanies
Product sample of The Cooper Companies

The forward P/E ratio determines the business value relative to expected earnings for the coming year. The current forward P/E of The Cooper Companies (COO), which stands at 13.30, reflects market expectations for capital growth rates. This ratio measures the investment payback period based on future cash flows. For The Cooper Companies, the stability of this metric is supported by low attrition among highly qualified engineers and technologists. Preserving unique intellectual capital minimizes operational risks, justifying the current market valuation.

Competitors of The Cooper Companies (COO)

Forward P/E Multiple BSX|Market Cap to Projected Earnings Edwards|ResMed Corp - Projected Price to Earnings|PODD (Insulet Inc.) - Price to Expected Earnings Ratio|Zimmer Biomet Holdings, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio aligntech.com|GMED: Forward P/E Multiple|Price to Future Earnings Ratio TMDX|Projected Price to Earnings ATEC|AORT: Future Price to Earnings Multiple|Future Price to Earnings Enovis Corporation (ENOV)|Projected Price to Earnings integralife.com IART|Forward P/E Multiple ESTA (Establishment Labs Holdings Inc.)|Beta Bionics, Inc. (BBNX) - Projected Price to Earnings Ratio|Iradimed - Forward P/E Multiple|EMBC (Embecta Health) - Price to Future Earnings Ratio|TNDM: Forward P/E Multiple|AXGN - Market Cap to Projected Earnings|SIBN (SI-BONE) - Forward P/E Multiple|Projected Price to Earnings Orthofix Medical (OFIX)|Forward P/E Multiple BVS|Forward P/E Multiple orthopediatrics.com (KIDS)|Future Price to Earnings Treace Medical Concepts TMCI|blade.com - Future Price to Earnings|CARL: Projected Price to Earnings|Future Price to Earnings Multiple RXST (RxSight Inc)|CLPT: Forward P/E Multiple|Projected Price to Earnings Ratio Stereotaxis Corporation (STXS)|Future Price to Earnings Neuronetics, Inc.|SGHT - Forward Price to Earnings Multiple|Projected Price to Earnings OBIO (Orchestra BioMed, Inc.)|Forward P/E Multiple anikatherapeutics.com (ANIK)|Forward P/E Multiple NSPR (InspireMD Corp)|Market Cap to Projected Earnings Jin Medical International Ltd. (ZJYL)|VANI - Future Price to Earnings|Price to Expected Earnings Ratio XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Projected Price to Earnings Modular Medical, Inc.|MYO (Myomo, Inc) - Forward P/E Multiple|Projected Price to Earnings Ratio Envoy Medical Inc COCH|Future Price to Earnings Vivos Therapeutics (VVOS)|envveno.com - Price to Future Earnings Ratio|Sintx Technologies, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio TNON (Tenon Medical Inc.)|LFWD: Projected Price to Earnings|Autonomix Medical, Inc. - Market Cap to Future Earnings Ratio|IVF: Forward P/E Multiple|bonebiologics.com - Future Price to Earnings Multiple|AXNX (Axonics) - Forward P/E Multiple|Projected Price to Earnings Ratio BIOLASE Inc. BIOL|Projected Price to Earnings DYNT (Dynatronics Corporation)|FNA (paragon28.com) - Future Price to Earnings Multiple|Forward P/E Multiple INVO (INVO Bioscience)